Governance model
The Novo Nordisk Way of Management forms the values-based governance framework for the company and is an integrated part of the company’s corporate governance. Thus, our corporate governance framework takes into consideration codes and regulations and the Novo Nordisk Way of Management.
Codes and regulations
As an international company listed on the stock exchanges in Copenhagen, New York and London, Novo Nordisk is in compliance with Danish and - as a foreign listed issuer - US and UK securities laws including the US Sarbanes-Oxley Act.
Further Novo Nordisk is in full compliance with the Danish Corporate Governance Recommendations, and is - as a foreign listed issuer - in general in compliance with corporate governance standards on New York and London Stock Exchanges.
It is Novo Nordisk's intent to seek compliance and adapts its procedures to align with current applicable codes to the extent possible and desirable. See a detailed review of Novo Nordisk's compliance with and deviations from codes on corporate governance designated by stock exchanges in Copenhagen, New York and London.
Novo Nordisk Way of Management
Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. This statement on sustainable development underlining, that the Triple Bottom line approach is part of Novo Nordisk Way of Management.
The Novo Nordisk Way of Management forms the values-based governance framework for the company. From vision to policies, it explicates how values are put into action. It is sufficiently specific to guide decision-making, yet at the same time allows for the adoption of new, supporting guidelines, policies or practices in response to evolving societal expectations or business developments.
Novo Nordisk holds itself accountable to shareholders for its performance. The accuracy, completeness and reliability of the information provided in the company's reporting is verified through internal controls, assurance and independent audits.
Reporting is the tool through which shareholders can assess the actions of the Board, and can, at the Annual General Meeting, query them. Integrity and values are the spine of Novo Nordisk's corporate culture and must never be compromised. These are essential elements of the control environment, affecting the design, administration, and monitoring of other internal control components.
This is the message conveyed to employees, as laid down by the Novo Nordisk Way of Management.
